Phreesia (PHR) Osake Kurssi

Phreesia Inc is primarily active in the healthcare industry.

Some of the main competitors of Phreesia Inc in the market include athenahealth, Cerner Corporation, and athenathealth.

Phreesia Inc is a leading healthcare technology company that specializes in patient intake solutions. Founded in 2005, Phreesia has revolutionized the way healthcare organizations collect patient information, automate workflows, and enhance the patient experience. With their innovative platform, Phreesia has helped thousands of healthcare providers streamline their operations and improve patient engagement. By offering a patient-centric approach, Phreesia has become a trusted partner in the industry, empowering healthcare organizations to deliver high-quality care while reducing administrative burdens. With a strong track record of success and a commitment to innovation, Phreesia continues to be at the forefront of transforming healthcare delivery.

Phreesia Inc has achieved several significant milestones over the years. One of the notable achievements is their successful initial public offering (IPO) in July 2019, which allowed the company to raise substantial capital to fuel their growth. Furthermore, Phreesia has consistently expanded its client base, forging partnerships with numerous leading healthcare organizations across the United States. The company's innovative platform, which streamlines patient intake and payment processes, has garnered recognition and accolades, including being named one of the "50 Most Innovative Companies" by Fast Company in 2020. Phreesia's commitment to driving healthcare efficiency and enhancing patient experiences has positioned them as a prominent player in the industry.

Phreesia Inc is primarily present in the United States.

Phreesia Inc is a healthcare technology company that aims to improve patient experiences and streamline administrative tasks. With a focus on innovation and efficiency, Phreesia provides a comprehensive platform for healthcare providers to manage patient intake, payments, and engagement. The company's corporate philosophy revolves around empowering patients, enhancing clinical decision-making, and improving healthcare outcomes. By leveraging cutting-edge technology and patient-centric solutions, Phreesia strives to revolutionize the healthcare industry. Through its robust platform and commitment to delivering a seamless experience, Phreesia Inc showcases a dedication to advancing patient care and transforming the healthcare landscape.

Analyytikot asettavat tällä hetkellä Phreesia-osakkeelle keskimääräisen tavoitehinnan 12,17 USD (mediaani: 12,00 USD), mikä merkitsee +15,9 % viimeisimpään hintaan verrattuna. Konsensus perustuu 23 analyytikkoarvioon.

Phreesia Analyytikkojen kursstavoitteet 2026

23 analyytikkoa arvioi tällä hetkellä Phreesia-osaketta: 14 suosittaa ostoa, 9 pitoa ja 0 myyntiä.

Phreesia Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Phreesia-osake noteerataan hintaan 9,38 EUR (10,50 USD).

Phreesia-osake (PHR) on listattuna 5 pörssissä, muun muassa: NYSE (PHR), London (0A23.L), Frankfurt (19P.F), München (19P.MU).

Phreesia Inc is a provider of technology-enabled services that optimize and improve patient traffic in medical practices and healthcare clinics. The company was founded in 2005 and is headquartered in New York City. Phreesia offers a wide range of services, such as patient registration, data entry, insurance verification, bill payment, appointment scheduling, and patient feedback. One of the company's most innovative products is the PhreesiaPad, an electronic tablet that automates paperwork during patient registration in the doctor's office. Phreesia has focused on the outpatient healthcare market, particularly medical practices and health centers, and has garnered numerous large clients, such as NewYork-Presbyterian Hospital and Duke University Medical Center. The company has developed comprehensive software that serves as the interface between physicians, insurance companies, and patients. Phreesia's core business is a subscription model, where customers pay a monthly fee to access the various services offered by the company. The company also partners with insurance companies to directly offer their services to patients. This leads to greater cost transparency and facilitates collaboration between physicians and insurance companies. Phreesia recently invested in telemedicine by partnering with SimplyWell, a digital health coaching company. This partnership allows Phreesia to offer a comprehensive platform for telemedicine and digital health solutions. Overall, Phreesia has developed a business model that enables easier collaboration and improves communication and transparency between physicians, patients, and insurance companies. By providing a comprehensive software solution that takes into account both the workflow in the practice and the requirements and expectations of patients, Phreesia has secured a solid position in the healthcare market.

liikevaihto Phreesia on 473,64 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

voitto Phreesia on 2,31 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Phreesia:n hinta-voitto-suhde (P/E) on tällä hetkellä 284,42. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Phreesia-osakkeen arvostusta.

Phreesia:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,38. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Phreesia-osakkeen arvostuskennuslukuna.

Phreesia:n Eulpool-laatuscore on 4/10.

Phreesia:n ISIN on US71944F1066. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Phreesia:n WKN on A2PMY3. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Phreesia:n ticker on PHR. Tämä pörssinoteeraus käytetään Phreesia-osakkeiden kauppaan pörssissä.